Prezista ( Darunavir 400mg/Tab )

1
6??
6??
????????
??????????(102.5) ..p.1 ????????
p.2 ????
p.3 ????QA p.4 ???????????
?? p.4

• Prezista ( Darunavir 400mg/Tab )

??? ???? PREZISTA????ritonavir (PREZISTA/rtv)? ??????????????,??? ???????? (HIV-1)???????? ??? ?????????????????, ???????????????????? ???????????????????? ,???????????? HIV treatment-naïve Adults, 800 mg qd with ritonavir 100 mg qd.HIV treatment-experienced Adults, 600 mg bid with ritonavir 100 mg bid.Children gt6 years gt 20 kg to lt 30 kg 375 mg bid with ritonavir 50 mg bid.gt 30 kg to lt 40 kg 450 mg bid with ritonavir 60 mg bid.gt 40 kg 600 mg bid with ritonavir 100 mg bid.

• ????????????

?? ?? ?????? ? ? ?????? ???????
5/6 Mopride Mosapride citrate 5mg/Tab ???????????????????????????????,???????????,???????????????????????????
5/7 Seroquel XR Quetiapine XR 200mg/Tab ???KC101?,??????,???????????????
5/7 Arcoxia Etoricoxib 60mg/Tab ???????,??Merck????Frosst Iberica S.A
5/20 Bojum Meropenem trihydrate 500mg/Vial ???102?5???,??????,??????-???????-??
5/20 Lodopin Zotepine 50mg/Tab ?????5320???????
5/20 Avastin Bevacizumab 25mg/ml ,4ml/Vial ????????,????????????????????????
5/22 ??????SALE03 Salicylic acid oint ?102?7?1???,??????,??102?7?1???????????? ??????SALE03 Salicylic acid oint ?102?7?1???,??????,??102?7?1???????????? ??????SALE03 Salicylic acid oint ?102?7?1???,??????,??102?7?1???????????? ??????SALE03 Salicylic acid oint ?102?7?1???,??????,??102?7?1????????????
Norvir ( Ritonavir 100mg/Cap )
??? ???? ????????????????? ????????(HIV)???? ??? ???????????????????, ????, ????????????,????? ???? Adults adolescents, initially, 300 mg q12h, increase by 100 mg q12h every 2-3 days, up to max. 600 mg q12h. If used as a pharmacokinetic enhancer of another HIV protease inhibitor, 100-400 mg qd.Children infants gt 1 mo, 250 mg/m2/dose q12h, increase by 50 mg/m2/dose q12h every 2-3 days, until 350-400 mg/m2/dose q12h max. 600 mg q12h.
-1-
-2-
2
?????? ? ?
?????? ? ?
? ???? ???
? ???? ???
?????? ? ?
?????? ? ?
? ???? ? ? ? ???? ? ?
? ???? ? ? ? ???? ? ?
6??
6??
??

• 
  ????QA
  ??? ??

BRCA1 ?BRCA2
Q1 2013/05/21 from?? ?????????????,??????????,???... ????????,???Ofloxacin?Danzen?Ponstan?Panadol?Tagamet,??3?,?????? ????,????????????????,?????? DEXCHLORPHENIRAMINE ??1.00TAB ??1? Kingcort ??4.00TAB ????2? Mylanta ??2.00TAB ????2? CETIRIZINE HYDROCHLO ??1.00TAB ?? Betasol Cream ??3.33G ????2?(??)
A1 ???????????????????????,??????????????????????,????????????? Dexchlorpheniramine B??Kingcort (Triamcinolone) C ?,Mylanta C ?,Cetirizine B ? (B?????????,?????????,?????????????????????????,?????????????????????????C ????????????????,?????????????????????????) FromMicromedex
(?)??BRCA1 ?BRCA2?(? BREAST CANCER 1 ? BREAST CANCER 2 ???) ????2??????????,?????????????? ??????????,??????????????? ???????3?4????????,????5-10???????????????????????????????????,???????????? ???????BRCA1?BRCA2??????????? BRCA1 ? BRCA2?????????????,??????/???????,?? BRCA1?BRCA2??????,???????????? 50?????????????????,??????????????,????????????????(??????)???,????????????????????????? ????????,?????????????BRCA1?BRCA2????????,??????,?????????? BRCA1/BRCA2 ???? (1)????????????????? (2)???????????????????????,?????50???? (3)?????????? (4)???????????????? (5)????????????????????? (6) ????????? (7)???????????????? (?)????? ???????????????????,?????? BRCA1 ? BRCA2 ??????????????????????????,????????????????????????????????,??????????????????????25????????????????,????????????????,30?????????????????? CA-125??????????????,??????????????????????????????????????????????????????????????90??????,??40????????????,????50????????????,????????????????,??????????????? ???? 1.Goldman M, O'Hair K. Women's health, breast health a review of the gynecologic effects of breast cancer. Obstet Gynecol Surv. 2009 Jul64(7)469-80. 2.Soltanian H, Okada H. Understanding genetic analysis for breast cancer and its implications for plastic surgery. Aesthet Surg J. 2008 Jan-Feb28(1)85-91. 3.Gunn S, Yeh IT, Lytvak I, Tirtorahardjo B, Dzidic N, Zadeh S, Kim J, McCaskill C, Lim L, Gorre M, Mohammed M. Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity. BMC Cancer. 2010 Jul 2810396. 4.Chin SF, Wang Y, Thorne NP, Teschendorff AE, Pinder SE, Vias M, Naderi A,Roberts I, Barbosa-Morais NL, Garcia MJ, Iyer NG, Kranjac T, Robertson JF, Aparicio S, Tavaré S, Ellis I, Brenton JD, Caldas C. Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. Oncogene. 2007 Mar 2226(13)1959-70. 5.Nelson HD, Huffman LH, Fu R, Harris EL U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005 Sep 6143(5)362-79. ????????? ???

• ?????????????

No.3 Sufen 200 mg VS. Senta 250 mg
?????????-GP/???
?????????-GP/235
No.4Prednisolone 5 mg VS. Cardiolol 5 mg
??
??????????-Y

• ??????????-023/U.L

-4-
-3-